BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3972403)

  • 1. Pulmonary large cell carcinoma expressing neuroendocrine markers: the morphological, biological, and neuroendocrine features of their cell lines and surgical cases.
    Kasai K; Kameya T; Kawakubo Y; Sato Y; Wada C; Itoh H
    Jpn J Cancer Res; 1992 Sep; 83(9):1002-10. PubMed ID: 1331003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
    Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J
    Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour markers: An overview.
    Malati T
    Indian J Clin Biochem; 2007 Sep; 22(2):17-31. PubMed ID: 23105677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of gastroenteropancreatic neuroendocrine tumors.
    Tan EH; Tan CH
    World J Clin Oncol; 2011 Jan; 2(1):28-43. PubMed ID: 21603312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact.
    Kontogianni K; Nicholson AG; Butcher D; Sheppard MN
    J Clin Pathol; 2005 Sep; 58(9):978-80. PubMed ID: 16126882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.
    Tanaka Y; Sano T; Qian ZR; Hirokawa M
    Endocr Pathol; 2004; 15(2):117-29. PubMed ID: 15299198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.
    Feldman SA; Eiden LE
    Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.
    Rosa P; Gerdes HH
    J Endocrinol Invest; 1994 Mar; 17(3):207-25. PubMed ID: 8051343
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of two cell lines derived from a histologically undifferentiated bronchial carcinoma expressing neuroendocrine markers.
    Wright-Perkins S; Daniel MR; Walker C
    In Vitro Cell Dev Biol Anim; 1994 Jul; 30A(7):450-9. PubMed ID: 7952514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
    Gosney JR; Gosney MA; Lye M; Butt SA
    Thorax; 1995 Feb; 50(2):116-20. PubMed ID: 7701447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in lung carcinoma.
    Addis BJ
    Thorax; 1995 Feb; 50(2):113-5. PubMed ID: 7701446
    [No Abstract]   [Full Text] [Related]  

  • 13. Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature.
    Blomjous CE; Thunnissen FB; Vos W; de Voogt HJ; Meijer CJ
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(6):505-12. PubMed ID: 2849230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric and flow cytometric analysis of small cell undifferentiated carcinoma of the bladder.
    Blomjous CE; Vos W; Schipper NW; De Voogt HJ; Baak JP; Meijer CJ
    J Clin Pathol; 1989 Oct; 42(10):1032-9. PubMed ID: 2555396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids.
    Weiler R; Feichtinger H; Schmid KW; Fischer-Colbrie R; Grimelius L; Cedermark B; Papotti M; Bussolati G; Winkler H
    Virchows Arch A Pathol Anat Histopathol; 1987; 412(2):103-9. PubMed ID: 2447696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.
    Sundaresan V; Reeve JG; Stenning S; Stewart S; Bleehen NM
    Br J Cancer; 1991 Aug; 64(2):333-8. PubMed ID: 1654075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors.
    Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV
    Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors.
    Nash SV; Said JW
    Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
    Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
    Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.